General Information of Drug Transporter (DT)
DT ID DTD0056 Transporter Info
Gene Name ABCC10
Transporter Name Multidrug resistance-associated protein 7
Gene ID
89845
UniProt ID
Q5T3U5
Exogenous Factors (drugs, dietary constituents, etc.) Modulating DT Activity (EFMDA)
Exogenous Factor Cyclosporine Approved Drug
DT Modulation Cyclosporine inhibits the transportation of 17-estradiol-(17--d-glucuronide) by ABCC10 [1]
Affected Drug/Substrate 17-estradiol-(17--d-glucuronide) Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-MRP7
Exogenous Factor Estradiol Approved Drug
DT Modulation Estradiol inhibits the transportation of Estradiol-17beta-glucuronide by ABCC10 [1]
Affected Drug/Substrate Estradiol-17beta-glucuronide Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-MRP7
Exogenous Factor Ethinyl estradiol Approved Drug
DT Modulation Ethinyl estradiol inhibits the transportation of Estradiol-17beta-glucuronide by ABCC10 [1]
Affected Drug/Substrate Estradiol-17beta-glucuronide Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-MRP7
Exogenous Factor Etoposide Approved Drug
DT Modulation Etoposide inhibits the transportation of Estradiol-17beta-glucuronide by ABCC10 [1]
Affected Drug/Substrate Estradiol-17beta-glucuronide Modulation Type Inhibition
Cell System Human embryonic kidney 293 cells (HEK293)-MRP7
Exogenous Factor Doxorubicin Approved Drug
DT Modulation Doxorubicin induces the activity of ABCC10 [2]
Exogenous Factor Paclitaxel Approved Drug
DT Modulation Paclitaxel induces the activity of ABCC10 [3]
Exogenous Factor Sulfinpyrazone Approved Drug
DT Modulation Sulfinpyrazone inhibits the activity of ABCC10 [3]
References
1 Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10). Mol Pharmacol. 2003 Feb;63(2):351-8.
2 Human ATP-binding cassette transporter ABCC10: expression profile and p53-dependent upregulation. J Exp Ther Oncol. 2004 Oct;4(3):239-46.
3 MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer. Mol Cancer Ther. 2008 May;7(5):1150-5.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.